- Home
- GS vs ABT Comparison
GS vs ABT Comparison
Compare GS & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GS
- ABT
- Stock Information
- Founded
- GS 1869
- ABT 1888
- Country
- GS United States
- ABT United States
- Employees
- GS N/A
- ABT N/A
- Industry
- GS Investment Bankers/Brokers/Service
- ABT Medical/Dental Instruments
- Sector
- GS Finance
- ABT Health Care
- Exchange
- GS Nasdaq
- ABT Nasdaq
- Market Cap
- GS 182.7B
- ABT 204.9B
- IPO Year
- GS 1999
- ABT N/A
- Fundamental
- Price
- GS $566.21
- ABT $114.21
- Analyst Decision
- GS Buy
- ABT Buy
- Analyst Count
- GS 17
- ABT 15
- Target Price
- GS $559.75
- ABT $129.80
- AVG Volume (30 Days)
- GS 2.0M
- ABT 4.7M
- Earning Date
- GS 01-15-2025
- ABT 01-22-2025
- Dividend Yield
- GS 2.12%
- ABT 1.93%
- EPS Growth
- GS 64.86
- ABT 12.04
- EPS
- GS 34.06
- ABT 3.29
- Revenue
- GS $49,387,000,000.00
- ABT $41,217,000,000.00
- Revenue This Year
- GS $17.81
- ABT $5.73
- Revenue Next Year
- GS $5.55
- ABT $7.17
- P/E Ratio
- GS $16.62
- ABT $34.72
- Revenue Growth
- GS 11.97
- ABT 3.15
- 52 Week Low
- GS $372.07
- ABT $99.71
- 52 Week High
- GS $612.73
- ABT $121.64
- Technical
- Relative Strength Index (RSI)
- GS 43.60
- ABT 46.60
- Support Level
- GS $544.49
- ABT $111.28
- Resistance Level
- GS $596.32
- ABT $114.15
- Average True Range (ATR)
- GS 11.93
- ABT 1.77
- MACD
- GS -6.71
- ABT -0.28
- Stochastic Oscillator
- GS 32.45
- ABT 47.56
About GS Goldman Sachs Group Inc. (The)
Goldman Sachs is a leading global investment banking and asset management firm. Approximately 20% of its revenue comes from investment banking, 45% from trading, 20% from asset management and 15% from wealth management and retail financial services. Around 60% of the company's net revenue is generated in the Americas, 15% in Asia, and 25% in Europe, the Middle East, and Africa.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.